Please wait a minute...
文章检索
预防医学  2020, Vol. 32 Issue (5): 460-465    DOI: 10.19485/j.cnki.issn2096-5087.2020.05.007
  论著 本期目录 | 过刊浏览 | 高级检索 |
诊室血压联合动态血压监测诊断高血压研究
丁芳1, 2, 俞蔚1, 2, 胡世云1, 2, 宣诚3, 俞柳燕4, 陈奇峰5, 范敏华6, 刘庆敏7, 徐小玲1, 2, 严静1
1.浙江医院,浙江 杭州 310013;
2.浙江省心脑血管病防治研究中心;
3.诸暨第二人民医院;
4.诸暨市疾病预防控制中心;
5.绍兴市疾病预防控制中心;
6.杭州市江干区闸弄口社区卫生服务中心;
7.杭州市疾病预防控制中心
Office blood pressure combined with ambulatory blood pressure monitoring in hypertension diagnosis
DING Fang*, YU Wei, HU Shiyun, XUAN Cheng, YU Liuyan, CHEN Qifeng, FAN Minhua, LIU Qingmin, XU Xiaoling, YAN Jing
The Provincial Center for Cardio-Cerebral-Vascular Disease, Zhejiang Hospital, Hangzhou, Zhejiang 310013, China
全文: PDF(533 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 评价诊室血压(OBP)联合动态血压监测(ABPM)诊断高血压的价值。方法 于2015—2018年选取诸暨市和杭州市的4个社区161名无高血压病史,且首日OBP为120~159 mm Hg/80~99 mm Hg的35~79岁常住居民为研究对象,测量ABPM(1周内)和非同日3次OBP(4周内),采用ROC曲线评价OBP(一日血压升高和三日血压均升高2种标准)联合ABPM(24 h、白天时段、夜间时段、任一时段平均血压升高4种标准)诊断隐蔽性高血压(MH)和白大衣高血压(WCH)的效果。结果 以三日OBP为金标准,一日OBP联合4种ABPM标准诊断MH的ROC曲线下面积(AUC)为0.79~0.81,灵敏度为57.58%~62.77%,特异度为100.00%;诊断WCH的AUC值为0.95~0.98,灵敏度为100.00%,特异度为88.96%~96.80%。Kappa值均<0.6,一致性不高。以任一时段ABPM升高为金标准,联合相同OBP标准时,24 h、白天时段和夜间时段标准诊断MH的AUC值为0.90~0.92,灵敏度为79.17%~83.90%,特异度为100.00%,Kappa值均>0.6,一致性较好;联合一日OBP标准时,Kappa值>0.8,一致性极好;诊断WCH的AUC值为0.95~1.00,灵敏度为100.00%,特异度为89.54%~99.37%,白天时段与任一时段ABPM标准的Kappa值>0.6,一致性较好。结论 一日OBP可替代三日OBP用于排除MH和诊断WCH,但准确性不如三日OBP;24 h或白天时段替代任一时段ABPM标准是可行可靠的。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
丁芳
俞蔚
胡世云
宣诚
俞柳燕
陈奇峰
范敏华
刘庆敏
徐小玲
严静
关键词 高血压诊断诊室血压动态血压监测白大衣高血压隐蔽性高血压    
AbstractObjective To evaluate the effects of office blood pressure(OBP)combined with ambulatory blood pressure monitoring(ABPM)on the diagnosis of hypertension. Methods The residents aged 35-79 years without hypertension history,whose casual OBP were 120~159 mm Hg/80~99 mm Hg,were enrolled from 4 communities of Hangzhou and Zhuji from 2015 to 2018. They were performed OBP measurements on other two days in 4 weeks and ABPM in a week. There were 2 criteria of OBP as elevated OBP on the first day or in 3 different days,and 4 criteria of ABPM as elevated mean BP in 24 hours, daytime, nighttime and either of the above time. Receiver operating characteristic(ROC)curve was employed to evaluate the effects of different OBP criteria combined with ABPM criteria on the diagnosis of masked hypertension(MH)and white-coat hypertension(WCH). Results Taking 3-day-OBP as a golden standard,the 1-day-OBP with 4 ABPM criteria had the areas under the ROC curve(AUC)of 0.79-0.81,sensitivity of 57.58%-62.77% and specificity of 100.00% in MH;had the AUC of 0.95-0.98,sensitivity of 100.00% and specificity of 88.96%-96.80% in WCH. The Kappa values were all less than 0.6,known as low consistency. Taking either time of ABPM as a golden standard,24 hours,daytime and nighttime ABPM criteria with OBP had the AUC of 0.90-0.92,sensitivity of 79.17%-83.90% and specificity of 100.00% in MH(all Kappa>0.6),when with 1-day-OBP,the Kappa values were all more than 0.8,known as high consistency;had the AUC of 0.95-1.00,sensitivity of 100.00% and specificity of 89.54%-99.37% in WCH,the Kappa values of daytime ABPM were all more than 0.6,known as high consistency. Conclusions If limited by options, 1-day-OBP could be used instead of 3-day-OBP for detection of WCH or exclusion of MH yet with less accuracy; 24 hours or daytime ABPM instead of either time of ABPM was reliable.
Key wordshypertension    diagnosis    office blood pressure    ambulatory blood pressure monitoring    white-coat hypertension    masked hypertension
收稿日期: 2019-11-04      修回日期: 2020-01-19      出版日期: 2020-05-10
中图分类号:  R544.1  
通信作者: 俞蔚,E-mail:yuweipost@163.com   
作者简介: 丁芳,博士,副主任医师,主要从事心血管病社区防治研究工作
引用本文:   
丁芳, 俞蔚, 胡世云, 宣诚, 俞柳燕, 陈奇峰, 范敏华, 刘庆敏, 徐小玲, 严静. 诊室血压联合动态血压监测诊断高血压研究[J]. 预防医学, 2020, 32(5): 460-465.
DING Fang, YU Wei, HU Shiyun, XUAN Cheng, YU Liuyan, CHEN Qifeng, FAN Minhua, LIU Qingmin, XU Xiaoling, YAN Jing. Office blood pressure combined with ambulatory blood pressure monitoring in hypertension diagnosis. Preventive Medicine, 2020, 32(5): 460-465.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2020.05.007      或      http://www.zjyfyxzz.com/CN/Y2020/V32/I5/460
[1] 《中国高血压防治指南》修订委员会. 中国高血压防治指南2018年修订版[J]. 心脑血管病防治, 2019, 19(1):1-44.
[2] WILLIAMS B, MANCIA G, SPIERING W, et al.2018 ESC/ESH Guidelines for the management of arterial hypertension[J]. Eur Heart J, 2018, 39(33): 3021-3104.
[3] KARIO K, SHIN J, CHEN C H, et al.Expert panel consensus recommendations for ambulatory blood pressure monitoring in Asia: the HOPE Asia network[J]. J Clin Hypertens (Greenwich), 2019, 21(9): 1250-1283.
[4] 王继光, 吴兆苏, 孙宁玲, 等. 动态血压监测临床应用中国专家共识[J]. 中华高血压杂志, 2015, 23(8): 727-730.
[5] KANG Y Y, LI Y, HUANG Q F, et al.Accuracy of home versus ambulatory blood pressure monitoring in the diagnosis of white-coat and masked hypertension[J]. J Hypertens, 2015, 33(8):1580-1587.
[6] TANG W, HU J, ZHANG H, et al.Kappa coefficient: a popular measure of rater agreement[J]. Shanghai Arch Psychiatry, 2015,27(1):62-67.
[7] PARATI G, STERGIOU G, O'BRIEN E, et al. European society of hypertension practice guidelines for ambulatory blood pressure monitoring[J]. J Hypertens, 2014,32(7): 1359-1366.
[8] HEAD G A, SHAW J E, DUNSTAN D W, et al.Hypertension, white-coat hypertension and masked hypertension in Australia: findings from the Australian Diabetes, Obesity, and Lifestyle Study 3[J]. J Hypertens, 2019, 37(8): 1615-1623.
[9] PEACOCK J, DIAZ K M, VIERA A J, et al.Unmasking masked hypertension:prevalence,clinical implications,diagnosis, correlates and future directions[J]. J Hum Hypertens, 2014, 28(9): 521-528.
[10] NASOTHIMIOU E G, TZAMOURANIS D, RARRA V, et al.Diagnostic accuracy of home vs. ambulatory blood pressure monitoring in untreated and treated hypertension[J]. Hypertens Res, 2012,35(7):750-755.
[11] BRGULJAN-HITIJ J, THIJS L, LI Y, et al.Risk stratification by ambulatory blood pressure monitoring across JNC classes of conventional blood pressure[J]. Am J Hypertens, 2014,27(7): 956-965.
[12] ZHANG D Y, GUO Q H, AN D W, et al.A comparative meta-analysis of prospective observational studies on masked hypertension and masked uncontrolled hypertension defined by ambulatory and home blood pressure[J]. J Hypertens, 2019,37(9): 1775-1785.
[13] PIERDOMENICO S D, PIERDOMENICO A M, COCCINA F, et al.Prognostic value of masked uncontrolled hypertension[J].Hypertension, 2018,72(4): 862-869.
[14] BOOTH J N, DIAZ K M, SEALS S R, et al.Masked hypertension and cardiovascular disease events in a prospective cohort of blacks: The Jackson Heart Study[J]. Hypertension, 2016, 68(2):501-510.
[15] BANEGAS J R, RUILOPE L M, DE LA SIERRA A, et al. Relationship between clinic and ambulatory blood-pressure measurements and mortality[J]. N Engl J Med, 2018, 378(16): 1509-1520.
[16] ANSTEY D E, PUGLIESE D, ABDALLA M, et al.An update on masked hypertension[J]. Curr Hypertens Rep, 2017,19(12):94.
[17] KUSHIRO T, KARIO K, SAITO I, et al.Effectiveness of olmesartan-based treatment on home and clinic blood pressure in elderly patients with masked and white coat hypertension[J]. Hypertens Res, 2015, 38(3):178-185.
[18] SOVA M, SOVOVA E, HOBZOVA M, et al.The effect of continuous positive airway pressure therapy on the prevalence of masked hypertension in obstructive sleep apnea patients[J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2015,159(2): 277-282.
[19] THAKKAR H V, POPE A, ANPALAHAN M.Masked hypertension: a systematic review[J]. Heart Lung Circ,2020,29(1):102-111.
[1] 王梦琴, 柴荟琳, 郭宇燕, 任敬娟, 梁瑞峰. 山西省农村居民高血压防治知识、态度、行为调查[J]. 预防医学, 2023, 35(7): 563-569.
[2] 沈益妹, 章奇, 朱新凤, 丁晶莹, 俞梅华. 湖州市血压控制未达标高血压患者慢性病共病及影响因素分析[J]. 预防医学, 2023, 35(6): 541-545,550.
[3] 张红, 胡志明, 潘晓锋, 朱梦胜, 戴伟丽, 谢伊丽, 诸建方. 社区高血压患者Triangle分层分级管理效果评价[J]. 预防医学, 2023, 35(4): 350-354,358.
[4] 靳明英, 沈蔚, 陈俊斐, 冯玲芳, 应士波, 夏海玲, 陈钧强, 陈祎秋, 蒋兆强, 楼建林. 长链非编码RNA JPX诊断间皮瘤及预后的价值研究[J]. 预防医学, 2023, 35(3): 235-238,242.
[5] 徐佳惠, 卢莎, 胡文胜. 组学技术在妊娠期高血压疾病发病机制及预测研究中的应用进展[J]. 预防医学, 2023, 35(1): 36-40.
[6] 傅君, 丁苗苗, 朱亚飞. 疾病诊断相关分组点数付费对产妇分娩住院费用的影响[J]. 预防医学, 2023, 35(1): 78-82.
[7] 郁小红, 钱棪梅, 周晨洁, 马越, 唐艳超, 邹玲莉. 应用TreeNet算法建立原发性高血压早期预测模型[J]. 预防医学, 2022, 34(9): 923-927.
[8] 林天祥, 邱银伟, 汪炜, 赵艳荣, 姜学文, 杨清. 基于基本公共卫生服务项目构建中老年人群高血压风险评估模型[J]. 预防医学, 2022, 34(8): 816-820.
[9] 关云琦, 梁明斌, 潘劲, 龚巍巍, 王浩, 周晓燕, 戴品远, 李娜, 钟节鸣, 胡如英. 浙江省成年人睡眠时间与高血压的关联研究[J]. 预防医学, 2022, 34(7): 681-686.
[10] 刘弢, 张鹏, 张传会, 李辉. 2016—2020年湖州市疑似职业病报告病例特征及诊断情况[J]. 预防医学, 2022, 34(7): 696-699.
[11] 杨娟, 李肖晓, 程蕊蕊, 诸葛瑾慧, 吾孜木·吉格尔, 姚华, 张明琛. 墨玉县成年人群血脂异常调查[J]. 预防医学, 2022, 34(6): 590-594,599.
[12] 呼聪慧, 苏银霞, 阿力米热·阿布迪热依木, 姚华. 墨玉县居民代谢性疾病患病调查[J]. 预防医学, 2022, 34(5): 519-524.
[13] 赵信星, 王长义, 戴舒红, 陈洪恩, 徐珊, 梁晓峰. 南山区高血压患者吸烟和戒烟情况调查[J]. 预防医学, 2022, 34(5): 449-455.
[14] 章群, 张丹丹, 王爱红, 屈凌燕, 胡群雄, 王雪英. 数字X线检查北仑区成人体表照射剂量参考值研究[J]. 预防医学, 2022, 34(4): 400-403,407.
[15] 郑帅印, 李富业, 谢尔瓦妮古丽·阿卜力米提, 李砥. 克拉玛依市35~75岁体检人群高血压、糖尿病、血脂异常调查[J]. 预防医学, 2022, 34(3): 232-239.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed